The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

It took GLP-1 medications like Ozempic just seven years to surpass insulin as the the second most common treatment for type 2 ...

Health experts are now looking at whether semaglutide can also curb alcohol cravings among addicts. A look at how this GLP-1 category drug functions in humans.

Updated European guidelines for metabolic dysfunction–associated steatotic liver disease stressed a higher risk in people ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

Earlier this year, when Clarkson had Whoopi Goldberg as a guest on “The Kelly Clarkson Show,” she revealed that her recent weight loss has been aided by weight loss medication, though she did ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...